Mojgan Devouassoux-Shisheboran Selected Research

Mojgan Devouassoux-Shisheboran Research Topics

Disease

40	Neoplasms (Cancer) 02/2024 - 01/2003
7	Carcinogenesis 01/2023 - 01/2003
6	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2003
5	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 10/2015
5	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 11/2017
5	Carcinoma (Carcinomatosis) 09/2023 - 10/2011
3	Leiomyoma (Uterine Fibroids) 03/2024 - 06/2011
3	Disease Progression 10/2023 - 10/2012
3	Endometrial Neoplasms (Endometrial Cancer) 08/2023 - 07/2019
3	Infertility (Sterility) 01/2021 - 03/2018
3	Adenocarcinoma of Lung 07/2015 - 01/2012
3	Seminoma 08/2006 - 01/2003
2	Pseudomyxoma Peritonei 02/2024 - 02/2024
2	Endometrial Stromal Sarcoma 10/2023 - 11/2022
2	Inflammation (Inflammations) 08/2023 - 03/2016
2	Ovarian Epithelial Carcinoma 11/2021 - 11/2014
2	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 10/2021 - 01/2017
2	Infections 01/2021 - 03/2016
2	Rupture 01/2021 - 04/2019
2	Trophoblastic Neoplasms (Trophoblastic Tumor) 01/2020 - 07/2019
2	Sertoli-Leydig Cell Tumor 05/2016 - 08/2006
2	Melanoma (Melanoma, Malignant) 03/2015 - 08/2005
2	Lung Neoplasms (Lung Cancer) 01/2014 - 01/2012
1	Endometriosis 01/2024
1	Hemorrhage 01/2024
1	Hypersensitivity (Allergy) 08/2023
1	Angiomatoid Fibrous Histiocytoma 06/2023
1	COVID-19 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Necrosis 01/2023
1	Mucormycosis 01/2023
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2023
1	Persistent Mullerian duct syndrome 11/2022
1	Carcinosarcoma 01/2022
1	Uveal melanoma 01/2022
1	Hydatidiform Mole (Molar Pregnancy) 10/2021
1	Papillomavirus Infections 09/2021
1	Leukemia 01/2021

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2003
7	RNA (Ribonucleic Acid)IBA 10/2023 - 10/2015
4	Hormones (Hormone)IBA 11/2023 - 08/2006
4	Netrin-1IBA 11/2023 - 03/2016
4	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 01/2014
4	PlatinumIBA 01/2022 - 11/2014
4	Biomarkers (Surrogate Marker)IBA 09/2021 - 10/2016
4	Transcription Factors (Transcription Factor)IBA 07/2019 - 01/2012
3	Keratins (Keratin)IBA 06/2023 - 02/2006
2	LigandsIBA 11/2023 - 03/2016
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 10/2023 - 11/2022
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2023 - 07/2019
2	Estrogens (Estrogen)FDA Link 10/2023 - 01/2019
2	Nucleic AcidsIBA 01/2023 - 04/2021
2	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 10/2021 - 01/2020
2	ClaudinsIBA 01/2021 - 01/2012
2	Formaldehyde (Formol)FDA Link 01/2020 - 01/2014
2	AntibodiesIBA 07/2019 - 07/2015
2	Cadherins (E-Cadherin)IBA 07/2019 - 07/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2019 - 11/2014
2	Carboplatin (JM8)FDA LinkGeneric 04/2019 - 11/2014
2	CateninsIBA 01/2019 - 02/2017
2	Messenger RNA (mRNA)IBA 01/2018 - 08/2006
1	Fumarate Hydratase (Fumarase)IBA 03/2024
1	antineoplaston A10 (A 10)IBA 01/2024
1	LipidsIBA 01/2024
1	Melanins (Melanin)IBA 01/2024
1	Contrast MediaIBA 11/2023
1	Radioisotopes (Radionuclides)IBA 11/2023
1	CollagenIBA 10/2023
1	Complementary DNA (cDNA)IBA 10/2023
1	Immune Checkpoint InhibitorsIBA 10/2023
1	Heavy MetalsIBA 08/2023
1	SynaptophysinIBA 06/2023
1	ChromograninsIBA 06/2023
1	FibrinIBA 01/2023
1	Cyclin EIBA 01/2023
1	Placental Lactogen (Human Placental Lactogen)IBA 01/2023
1	PromegaIBA 01/2023
1	Myosin-Light-Chain PhosphataseIBA 11/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2021
1	Levonorgestrel (Plan B)FDA LinkGeneric 01/2021
1	CoumestrolIBA 01/2021
1	Oral ContraceptivesIBA 01/2021

Therapy/Procedure

11	Therapeutics 11/2023 - 10/2012
7	Drug Therapy (Chemotherapy) 10/2023 - 10/2012
4	Cytoreduction Surgical Procedures 02/2024 - 12/2020
3	Lymph Node Excision (Lymph Node Dissection) 04/2021 - 04/2019
3	Salpingo-oophorectomy 01/2018 - 10/2011
2	Hyperthermic Intraperitoneal Chemotherapy 02/2024 - 02/2024
2	Radiotherapy 11/2023 - 01/2023
2	Combination Drug Therapy (Combination Chemotherapy) 10/2023 - 01/2020
2	Laparotomy 01/2021 - 04/2019
2	Conservative Treatment 01/2021 - 01/2018
1	Immunotherapy 10/2023
1	Neonatal Intensive Care 01/2023
1	Cesarean Section (Caesarean Section) 01/2023
1	Neoadjuvant Therapy 11/2021
1	Intrauterine Devices (Intrauterine Device) 01/2021